Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TIAB Vaginal Capsules for Prevention of Post-Hysterectomy Complications
NCT03791294Phase 3Unknown
- Sponsor
- University of Insubria
- Start
- Jan 2019
- Primary completion
- Jun 2019
- Modality
- Nanoparticles, Small Molecules
01
Overview
Phase 3, randomised, open-label trial in postoperative complications, surgical site infection (SSI), urinary tract infection (UTI) and 1 more (2 arms), sponsored by University of Insubria. Primary endpoints: Vaginal bleeding at 30 days, Vaginal vault infection at 30 days and 3 more. Status: unknown.
02
Conditions
postoperative complicationssurgical site infection (SSI)urinary tract infection (UTI)vaginal cuff dehiscence (VCD)
Beyond the preview
Go deeper on NCT03791294.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03791294.